COVID-19 test kit

IgAIgGIgM

OPTI Medical Systems has obtained CE marking for its OPTI SARS-CoV-2 Total Antibody Test for detection of total antibodies against SARS-CoV-2. The OPTI SARS-CoV-2 Total Antibody Test is an enzyme-linked immunosorbent assay (ELISA) that detects total antibodies (IgG, IgM, and IgA) against the receptor binding domain (RBD) of the spike (S) protein of SARS-CoV-2 in samples from human serum and plasma. Given that current vaccines have been developed to elicit antibodies against the receptor binding domain of the spike protein, this test is an excellent tool for assessing vaccine-elicited antibody uptake. A complete serology-based testing solution Detects total antibodies for broad sensitivity. Suitable for assessing vaccine-elicited antibody uptake. Limits the need for validation due to an extensive validation data report. Supported by an experienced technical team. Makes lab setup easy when ELISA readers and washers are utilized for a complete testing solution. Performance An internal study has demonstrated that the OPTI SARS-CoV-2 Total Antibody Test is an extremely sensitive test for evaluating antibody responses in people who have had one or both Moderna vaccinations. Similar results should be expected with other vaccines that use the RBD subunit of the spike protein.